Invention Grant
- Patent Title: SETBP1 inhibitors for the treatment of myeloid neoplasms and solid tumors
-
Application No.: US17057063Application Date: 2019-05-22
-
Publication No.: US12070462B2Publication Date: 2024-08-27
- Inventor: Yang Du , Nhu Nguyen
- Applicant: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Applicant Address: US MD Bethesda
- Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Current Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Current Assignee Address: US MD Bethesda
- Agency: Sheppard Mullin Richter & Hampton LLP
- International Application: PCT/US2019/033526 2019.05.22
- International Announcement: WO2019/226773A 2019.11.28
- Date entered country: 2020-11-19
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61K31/475 ; A61P35/00 ; C07K14/47
Abstract:
Chemical compounds for the treatment of myeloid neoplasms and solid tumors are described, where the compounds were identified through a screening process assessing the binding affinity of the compounds to a synthesized fragment of Setbp1 protein.
Public/Granted literature
- US20210205306A1 SETBP1 INHIBITORS FOR THE TREATMENT OF MYELOID NEOPLASMS AND SOLID TUMORS Public/Granted day:2021-07-08
Information query
IPC分类:
